Short Interest in InterCure Ltd. (NASDAQ:INCR) Rises By 96.2%

InterCure Ltd. (NASDAQ:INCR) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 46,500 shares, an increase of 96.2% from the December 31st total of 23,700 shares. Based on an average daily trading volume, of 41,200 shares, the short-interest ratio is presently 1.1 days. Approximately 0.2% of the shares of the stock are short sold.

InterCure Price Performance

Shares of INCR traded down $0.01 on Wednesday, hitting $1.68. The company’s stock had a trading volume of 25,187 shares, compared to its average volume of 14,133. InterCure has a fifty-two week low of $1.17 and a fifty-two week high of $3.72. The company has a 50 day moving average price of $1.54 and a 200 day moving average price of $1.78. The company has a quick ratio of 1.15, a current ratio of 1.78 and a debt-to-equity ratio of 0.15.

Hedge Funds Weigh In On InterCure

Institutional investors and hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC increased its stake in shares of InterCure by 30.9% in the second quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after buying an additional 10,700 shares in the last quarter. Jane Street Group LLC bought a new stake in InterCure during the 3rd quarter worth about $49,000. Finally, Virtu Financial LLC acquired a new stake in InterCure in the 3rd quarter valued at about $43,000. Institutional investors and hedge funds own 8.34% of the company’s stock.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.